Breast Cancer Immunodiagnosis and Immunotherapy

  • Roberto L. Ceriani

Table of contents

  1. Front Matter
    Pages i-xi
  2. Session I

    1. Front Matter
      Pages 1-1
    2. Grant MacLean, Alexander McEwan, Eleanor Mackie, Peter Fung, Carina Henningsson, Rao Koganty et al.
      Pages 3-11
    3. Robert D. Cardiff, Shoichiro Taniuchi, Daer He
      Pages 13-17
    4. Roberto L. Ceriani, Hector Battifora, Edward W. Blank, Jerry A. Peterson, Cindy Zoellner
      Pages 19-32
    5. Daniel F. Hayes, Miyako Abe, Javed Siddiqui, Carlo Tondini, Donald W. Kufe
      Pages 45-53
    6. R. Kinders, J. Slota, J. Patrick, C. Plate, I. Kafer, W. Caminiti et al.
      Pages 55-67
  3. Session II

    1. Front Matter
      Pages 69-69
    2. Joyce Taylor-Papadimitriou, Joy Burchell, Sandra Gendler, Martina Boshell, Trevor Duhig
      Pages 81-93
    3. Jerry A. Peterson, Edward Blank, Cindy Zoellner, Sean Enloe, Garrett Walkup, Roberto L. Ceriani
      Pages 95-103
  4. Session III

    1. Front Matter
      Pages 117-117
    2. Geoffrey L. Greene, Paul Gilna, Peter Kushner
      Pages 119-129
    3. Martine Perrot-Applanat, Jean-François Prud’homme, Mai-Thu Vu Hai, André Jolivet, Frédéric Lorenzo, Edwin Milgrom
      Pages 131-139
    4. Petra Kiene, Laura Kinsel, John Konrath, Geoffrey Greene, George Leight, Edwin Cox et al.
      Pages 141-147
    5. Edward J. Keenan, Debra Corbin
      Pages 149-159
    6. I. Tsarfaty, S. Chaitchik, M. Hareuveni, J. Horev, A. Hizi, D. H. Wreschner et al.
      Pages 161-169
    7. Noriaki Ohuchi, Minoru Akimoto, Shozo Mori, Donald W. Kufe, Jeffrey Schlom
      Pages 171-181
    8. Noriaki Ohuchi, Maria J. Merino, Darryl Carter, Jean F. Simpson, Susan Kennedy, Donald Kufe et al.
      Pages 183-192
  5. Session IV

    1. Front Matter
      Pages 193-193
    2. Rosemonde Mandeville, Christian Schatten, Norbert Pateisky, Marie-Josée Dicaire, Benoît Barbeau, Brigitte Grouix
      Pages 203-210
    3. Pei X. Xing, Kerry Reynolds, Joe J. Tjandra, Xi L. Tang, Damian F. J. Purcell, Ian F. C. McKenzie
      Pages 211-217
    4. Robert K. Oldham, Shuen-Kuei Liao, John R. Ogden, William H. Hubbard
      Pages 219-230
    5. Bruce J. Gould, Michael J. Borowitz, Eric S. Groves, Arthur E. Frankel
      Pages 231-236
    6. Paul A. Bunn Jr., David G. Dienhart, Raymond F. Schmelter, James L. Lear, Gary Miller, Duane C. Bloedow et al.
      Pages 237-248
  6. Back Matter
    Pages 249-259

About this book


The convening of the 3rd International Workshop on Monoclonal Antibodies and Breast Cancer had the character of a self-search exercise. After almost a decade of research in the basic and applied aspects of the use of serological means to diagnose and possibly treat breast cancer several milestones have been reached. Among them a clear understanding of immunopathological use and limitations of monoclonal antibodies against breast epithelium, the complete development and clinical use of immunoassays for circulating breast epithelial antigens, the striking advances in the diagnostic use of monoclonal antibodies to estrogen and progesterone receptor proteins and the first communications on proposed immunotherapeutic use of different conjugates of anti-breast antibodies. New areas of investigation have developed in our field, some which are reaching a full blossom while others are still facing obstacles and at times a re-definition of their goals and objectives. These meetings have acted in a way as a clearing house and have permitted their attendees to derive predictions that have helped shape future research and fine-tune objectives. But above all, the re-evaluation of past research at these Workshops and the renewed excitement brought to them by new information has helped generate a momentum and enthusiasm that assures for the future large scientific gains.


antibody antigen immunotherapy interferon proteins

Editors and affiliations

  • Roberto L. Ceriani
    • 1
  1. 1.John Muir Cancer and Aging Research InstituteWalnut CreekUSA

Bibliographic information